Vaccinex (NASDAQ:VCNX) Stock Price Up 11.1% – Time to Buy?

Vaccinex, Inc. (NASDAQ:VCNX)’s share price was up 11.1% on Tuesday . The company traded as high as $4.73 and last traded at $4.59. Approximately 166,955 shares traded hands during trading, an increase of 195% from the average daily volume of 56,660 shares. The stock had previously closed at $4.13.

Vaccinex Trading Up 11.1 %

The firm has a market cap of $11.93 million, a P/E ratio of -0.10 and a beta of 1.10. The business’s fifty day moving average price is $3.14 and its two-hundred day moving average price is $4.95.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Vaccinex stock. Point72 Asset Management L.P. raised its stake in shares of Vaccinex, Inc. (NASDAQ:VCNX) by 42.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 166,000 shares of the company’s stock after purchasing an additional 49,454 shares during the quarter. Point72 Asset Management L.P. owned 9.60% of Vaccinex worth $564,000 as of its most recent filing with the SEC. 50.11% of the stock is owned by institutional investors.

Vaccinex Company Profile

Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.